top of page
Sage Group News
The Sage Group Expands Team in Japan with Hideyuki Hirama of Gemseki in Tokyo As Partner
London, New York and Tokyo, July 6 2020 - The Sage Group Inc. today announced that Gemseki Japan, led by Hideyuki Hirama, will join its...
Sage Represents Cancer Prevention Pharmaceuticals: A Late Stage, $Billion Orphan Product Opportunity
Sage’s client, Cancer Prevention Pharmaceuticals (“CPP”; www.canprevent.com),is a late clinical stage company developing a unique, oral,...
Sage Group Represents Squarex's SQX770: A Novel Immunologic Approach for the Prevention of Cold
The Sage Group is pleased to announce it has been appointed to represent a product from Squarex LLC, SQX770, the only product which...
The Sage Group Expands Team in North America – Dr. Christine T. Fischette Joins as New Executive Dir
London, England and New York, February 17 2020 - The Sage Group Inc. today announced that Dr. Christine T. Fischette will join the firm...
OncoSec Announces Closing of the CGP/Sirtex Transaction
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)-- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company...
The Sage Group Expands Team – Dr. Clarissa Ceruti Joins As Executive Director
London, England and New York, February 5 2020 - The Sage Group, Inc. today announced that Dr. Clarissa Ceruti will join the firm as an...
Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients: O
Sage Group is working with medac GmbH who have developed Trecondi®, (Treosulfan), as a superior drug in conjunction with fludarabine...
Sage Represents BioHit Healthcare: Opportunity for Leadership in Nicotine-Free Smoking Cessation Usi
BioHit Healthcare has developed and gained approval in Europe for the Acetium® lozenge. This binds cigarette smoke-derived acetaldehyde...
bottom of page